Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

GeneNews closes concurrent private placement offerings for US$2.1 million

Fasken
Reading Time 1 minute read Subscribe
Client

GeneNews Limited

On November 12, 2010, GeneNews Limited (TSX:GEN) completed its two previously announced concurrent private placement offerings: one offering of units and another offering of five-year senior 15% redeemable convertible secured debentures. Through the concurrent offerings, GeneNews raised total gross proceeds of $2,125,452. GeneNews is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management based on disease-specific biomarkers. GeneNews was advised in this transaction by Fasken Martineau with a team that included Geoff Clarke, Brad Freelan, and Michael Shour (corporate/securities).

    Subscribe

    Receive email updates from our team

    Subscribe